The clinical trial industry has been steadily undergoing a data evolution. Data from remote capture devices, such as wearables and other novel sources (e.g., increasingly large health data repositories and electronic healthcare data), have gained importance. Proper management and utilization of such data allows sponsors to untether from a set roster of trial sites, focus directly on the patient, and create an ecosystem that relies more prominently on remote patient monitoring. Furthermore, with increasing accessibility to these new and emerging data sets, sponsors now have the opportunity to design nontraditional studies.
Medical and Regulatory Affairs
Clinical Data Trends: Transforming Data Access/Analysis
By Stacy Weil and Nach Davé |March 16, 2021